These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1671310)

  • 1. Murine CD2 mediates cellular immune responses in vivo.
    Bromberg JS; Chavin KD; Lau HT; Altevogt P; Kyewski BA; Guckel B; Naji A; Barker CF
    Transplant Proc; 1991 Feb; 23(1 Pt 1):856-8. PubMed ID: 1671310
    [No Abstract]   [Full Text] [Related]  

  • 2. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
    Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
    Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
    J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD2 mAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockade.
    Chavin KD; Qin L; Yon R; Lin J; Yagita H; Bromberg JS
    J Immunol; 1994 Apr; 152(8):3729-39. PubMed ID: 7908306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies.
    Chavin KD; Lau HT; Bromberg JS
    Transplantation; 1992 Aug; 54(2):286-91. PubMed ID: 1353913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effect of anti-CD4 monoclonal antibodies and cyclosporin A on murine fetal islet allograft survival.
    Burkhardt K; Charlton B; Mandel TE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2663-4. PubMed ID: 2495663
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a polyclonal anti-TNF antibody on cell-mediated immunity in vivo.
    Chavin KD; Bromberg JS; Kunkel SL; Naji A; Barker CF
    Transplant Proc; 1991 Feb; 23(1 Pt 1):847-8. PubMed ID: 1671309
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of rat pancreatic islet allograft survival by anti-CD2 monoclonal antibody treatment.
    Roark JH; Posselt AM; Campos L; Kim J; Chavin KD; Bromberg JS; Barker CF; Naji A
    Transplantation; 1992 Dec; 54(6):1098-9. PubMed ID: 1361253
    [No Abstract]   [Full Text] [Related]  

  • 10. Human CD2 is functional in CD2 transgenic mice.
    Monostori E; Lang G; Kioussis D; Cantrell DA; Zamoyska R; Brown MH; Crumpton MJ
    Immunology; 1991 Nov; 74(3):369-72. PubMed ID: 1685144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
    Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
    Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.
    Qin L; Chavin KD; Lin J; Yagita H; Bromberg JS
    J Exp Med; 1994 Jan; 179(1):341-6. PubMed ID: 7903681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.
    Hirsch R; Eckhaus M; Auchincloss H; Sachs DH; Bluestone JA
    J Immunol; 1988 Jun; 140(11):3766-72. PubMed ID: 3286764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of privileged sites and islet transplantation.
    Barker CF; Markmann JF; Posselt AM; Naji A
    Transplant Proc; 1991 Aug; 23(4):2138-42. PubMed ID: 1871831
    [No Abstract]   [Full Text] [Related]  

  • 16. Xenoreactive T-cell lines initiate pancreatic islet graft destruction in vivo.
    Wolf L; Gill RG
    Transplant Proc; 1993 Feb; 25(1 Pt 1):440-1. PubMed ID: 8438369
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of L3T4 and Lyt-2 monoclonal antibodies on islet xenograft (rat to mouse) rejection.
    Kawai M; Gotoh M; Monden M; Yamamoto H; Ichikawa T; Valdivia LA; Mori T; Uenaka A; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2709-10. PubMed ID: 2495677
    [No Abstract]   [Full Text] [Related]  

  • 18. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice.
    Mandel T; Dillon H; Koulmanda M
    Transplant Proc; 1995 Dec; 27(6):3569. PubMed ID: 8540105
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo.
    Bromberg JS; Chavin KD; Altevogt P; Kyewski BA; Guckel B; Naji A; Barker CF
    Transplantation; 1991 Jan; 51(1):219-25. PubMed ID: 1670971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.